Home › Compare › PARNF vs O

PARNF vs O: Dividend Comparison 2026

PARNF yields 2500.00% · O yields 5.28%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PARNF wins by $80609755877.33M in total portfolio value
10 years
PARNF
PARNF
● Live price
2500.00%
Share price
$0.08
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$80609755877.37M
Annual income
$74,729,580,081,858,750.00
Full PARNF calculator →
O
Realty Income Corporation
● Live price
5.28%
Share price
$61.15
Annual div
$3.23
5Y div CAGR
15.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.2K
Annual income
$5,102.74
Full O calculator →

Portfolio growth — PARNF vs O

📍 PARNF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPARNFO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PARNF + O cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
PARNF pays
O pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PARNF
Annual income on $10K today (after 15% tax)
$212,500.00/yr
After 10yr DRIP, annual income (after tax)
$63,520,143,069,579,940.00/yr
O
Annual income on $10K today (after 15% tax)
$449.12/yr
After 10yr DRIP, annual income (after tax)
$4,337.33/yr
At 15% tax rate, PARNF beats the other by $63,520,143,069,575,600.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PARNF + O for your $10,000?

PARNF: 50%O: 50%
100% O50/50100% PARNF
Portfolio after 10yr
$40304877938.70M
Annual income
$37,364,790,040,931,930.00/yr
Blended yield
92.71%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on O right now

PARNF
No analyst data
O
Analyst Ratings
13
Buy
18
Hold
3
Sell
Consensus: Hold
Price Target
$64.00
+4.7% upside vs current
Range: $60.00 — $69.00
Altman Z
1.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PARNF buys
0
O buys
0
No recent congressional trades found for PARNF or O in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPARNFO
Forward yield2500.00% ✓5.28%
Annual dividend / share$2.00$3.23 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.1% ✓
Portfolio after 10y$80609755877.37M ✓$34.2K
Annual income after 10y$74,729,580,081,858,750.00 ✓$5,102.74
Total dividends collected$80198875900.38M ✓$20.7K
Payment frequencyquarterlymonthly
SectorStockREIT

Year-by-year: PARNF vs O ($10,000, DRIP)

YearPARNF PortfolioPARNF Income/yrO PortfolioO Income/yrGap
1← crossover$260,700$250,000.00$10,818$608.16+$249.9K → PARNF
2$6,370,070$6,091,121.50$11,787$741.68+$6.36M → PARNF
3$145,912,632$139,096,656.81$12,946$911.00+$145.90M → PARNF
4$3,133,830,814$2,977,704,297.75$14,345$1,127.94+$3133.82M → PARNF
5$63,122,812,060$59,769,613,088.96$16,056$1,409.05+$63122.80M → PARNF
6$1,192,683,724,131$1,125,142,315,226.76$18,171$1,777.83+$1192683.71M → PARNF
7$21,144,559,711,004$19,868,388,126,183.19$20,820$2,268.21+$21144559.69M → PARNF
8$351,818,906,448,043$329,194,227,557,269.44$24,188$2,929.90+$351818906.42M → PARNF
9$5,495,491,397,671,320$5,119,045,167,771,913.00$28,533$3,837.11+$5495491397.64M → PARNF
10$80,609,755,877,367,070$74,729,580,081,858,750.00$34,235$5,102.74+$80609755877.33M → PARNF

PARNF vs O: Complete Analysis 2026

PARNF — Stock

Parnell Pharmaceuticals Holdings Ltd, a commercial-stage pharmaceutical company, focuses on developing, manufacturing, and marketing animal pharmaceutical products worldwide. The company operates through four segments: Companion Animal, Production Animal - U.S., Production Animal - Rest of World, and Manufacturing Operations. It markets various products, including estroPLAN and GONAbreed reproductive hormone products for enhancing cattle breeding performance; Zydax for the treatment of osteoarthritis (OA) in dogs and horses; and Glyde, a nutraceutical product for the treatment of OA, as well as Parnell PROcept, which adds an additional injection of estroPLAN after the first injection. The company also offers mySYNCH, a digital tool to help veterinarians and producers optimize reproduction and maximize economic gains. Parnell Pharmaceuticals Holdings Ltd was incorporated in 2009 and is headquartered in Alexandria, Australia.

Full PARNF Calculator →

O — REIT

Realty Income, The Monthly Dividend Company, is an S&P 500 company dedicated to providing stockholders with dependable monthly income. The company is structured as a REIT, and its monthly dividends are supported by the cash flow from over 6,500 real estate properties owned under long-term lease agreements with our commercial clients. To date, the company has declared 608 consecutive common stock monthly dividends throughout its 52-year operating history and increased the dividend 109 times since Realty Income's public listing in 1994 (NYSE: O). The company is a member of the S&P 500 Dividend Aristocrats index. Additional information about the company can be obtained from the corporate website at www.realtyincome.com.

Full O Calculator →
📬

Get this PARNF vs O comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PARNF vs SCHDPARNF vs JEPIPARNF vs KOPARNF vs MAINPARNF vs STAGPARNF vs ADCPARNF vs NNNPARNF vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.